Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Belluscura PLC ( (GB:BELL) ) has issued an announcement.
Belluscura PLC is assessing the impact of newly proposed US tariffs on imports, which significantly affect their Portable Oxygen Concentrators and related components manufactured in China. The company has withdrawn its market guidance for the year ending December 2025 and plans to release further information once the situation is fully evaluated.
More about Belluscura PLC
Belluscura PLC is a UK-based medical device company that specializes in developing oxygen enrichment technology for various industries and therapies.
YTD Price Performance: -86.49%
Average Trading Volume: 1,420,391
Technical Sentiment Signal: Strong Buy
Current Market Cap: £5.02M
For detailed information about BELL stock, go to TipRanks’ Stock Analysis page.